Kite Pharma (KITE): FDA Official's Personal View On CAR-T Therapy - Jefferies

September 19, 2016 7:43 AM EDT Send to a Friend
Jefferies analyst, Biren Amin, reiterated his Buy rating on shares of Kite Pharma (NASDAQ: KITE) after attending an industry meeting ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login